Cancer clinical trials in the region Occitanie
132 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Phase 2
Lung cancer
#NCT04621188
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
ROS-1
Chemotherapy
Targeted therapy
Immunotherapy
Centre Hospitalier du Pays d'Aix (Aix-en-Provence), Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ), Centre Hospitalier Universitaire Angers (Angers ), Centre Hospitalier Annecy Genevois (Epagny Metz-Tessy), Centre Hospitalier Chauny (Chauny) (and 28 more...)
Intergroupe Francophone de Cancérologie Thoracique
Phase 2
Lung cancer
#NCT04526782
NSCLC (Non-Small Cell Lung Cancer)
Metastatic
BRAF
Chemotherapy
Surgery
Chemotherapy
Immunotherapy
Systemic Treatment-Naive
ALK
EGFR
ROS-1
Targeted therapy
Targeted therapy
Centre Hospitalier Universitaire Angers (Angers ), Institut Sainte Catherine (Avignon), Institut Bergonié (Bordeaux), Hôpital Ambroise-Paré AP-HP (Boulogne-Billancourt), Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest) (and 30 more...)
Intergroupe Francophone de Cancérologie Thoracique
Phase 2
Breast cancer
#NCT03915678
HER2 Negative
HR Negative
Metastatic
Systemic Treatment-Naive
Institut Bergonié (Bordeaux), Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest), Centre François Baclesse (Caen ), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Centre Oscar Lambret (Lille) (and 4 more...)
Institut Bergonié
Phase 2
Breast cancer
#NCT04666961
HR Positive
Localized
Systemic Treatment-Naive
BRCA 1/2
Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ), Institut Bergonié (Bordeaux), Centre Antoine Lacassagne (Nice), Hôpital Saint-Joseph (Paris), Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain) (and 2 more...)
Institut de Cancérologie de l'Ouest
Phase 2
Breast cancer
#NCT05296746
HER2 Negative
HR Positive
Locally Advanced
Systemic Treatment-Naive
Systemic Treatment-Naive
Clinique Sainte Anne (Strasbourg), Institut Sainte Catherine (Avignon), Centre Hospitalier de la Côte Basque (Bayonne), Centre Hospitalier Universitaire de Besançon (Besançon), Centre François Baclesse (Caen ) (and 24 more...)
Novartis
Phase 2
Breast cancer
#NCT05625087
HER2 Negative
HR Positive
Metastatic
PIK3CA
Hormone therapy
Systemic Treatment-Naive
Centre Hospitalier de la Côte Basque (Bayonne), CHU Amiens-Picardie (site sud) (Amiens), Clinique de l'Europe d'Amiens (Amiens), Centre Hospitalier d’Auxerre (Auxerre), Institut Sainte Catherine (Avignon) (and 35 more...)
UNICANCER
Phase 2
Prostate cancer
#NCT05826509
Adenocarcinoma
Localized
Systemic Treatment-Naive
Systemic Treatment-Naive
Centre Hospitalier Universitaire Angers (Angers ), Centre Hospitalier Universitaire de Bordeaux (Bordeaux), Hôpital Henri-Mondor AP-HP (Créteil), Centre Hospitalier Universitaire de Grenoble (La Tronche), Hôpital Claude Huriez (Lille) (and 11 more...)
Institut Claudius Regaud
Phase 2
Lung cancer
#NCT05498428
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
EGFR
Systemic Treatment-Naive
Targeted therapy
Immunotherapy
Centre François Baclesse (Caen ), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Institut Curie - Paris (Paris), Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain), Gustave Roussy (Villejuif) (and 1 more...)
Janssen
Phase 2
Lung cancer
#NCT05609578
NSCLC (Non-Small Cell Lung Cancer)
Non-squamous NSCLC
Locally Advanced
Metastatic
KRAS G12C
Chemotherapy
Immunotherapy
PDL1 Positive (1% <= X < 25%)
PDL1 Positive (25% <= X < 50%)
Targeted therapy
Targeted therapy
Centre Hospitalier Intercommunal Créteil (Créteil Cedex), Hôpital Larrey (Toulouse ), Hôpital Tenon AP-HP (Paris ), Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ), Institut Paoli-Calmettes (Marseille) (and 5 more...)
Mirati Thérapeutique Inc.
Phase 2
Lung cancer
#NCT05200481
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
ALK
Systemic Treatment-Naive
BRAF
EGFR
KRAS G12C
KRAS non G12C
MET
NTRK-1/2/3
RET
ROS-1
Targeted therapy
Targeted therapy
Centre Hospitalier Universitaire Angers (Angers ), Centre Hospitalier Universitaire de Besançon (Besançon), Hôpital Ambroise-Paré AP-HP (Boulogne-Billancourt), Hôpital Louis Pradel (Bron ), CHU Caen Normandie (Caen) (and 21 more...)
Intergroupe Francophone de Cancérologie Thoracique